Press Room

News / Jul 20, 2021

ASD-HIPROS Learning Lab at CPhI NA

Join our exclusive Learning Lab at CPhI North America

Amorphous Solid Dispersions formulation by Spray Drying ASDs | Hovione

During CPhI North America, Hovione will present a Learning Lab on ASD-HIPROS, to be held on July 29th. ASD-HIPROS is a new platform for quick and effective formulation screening for Amorphous Solid Dispersions by Spray Drying.

 

Join our expert and in just 20 minutes you will learn:

 

  1. Introduction to Hovione’s new formulation screening platform by Spray Drying
  2. Learn about the advantages of a platform that integrates in silico computational models, formulation, analytical development
  3. Get to know more about Hovione’s extensive expertise in Spray Drying

 

Learn more about the session

 

REGISTER NOW

 

 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025